您的位置: 首页 > 农业专利 > 详情页

COMBINATION THERAPY OF ANTIBODIES ACTIVATING HUMAN CD40 AND ANTIBODIES AGAINST HUMAN PD-L1
专利权人:
发明人:
Emily Rana Corse,Olivier Freytag,Christian Gerdes,Marine Le Clech,Hyam Levitsky,Marion OTT,Martin Stern,Wei Xu
申请号:
US15722585
公开号:
US20180051077A1
申请日:
2017.10.02
申请国别(地区):
US
年份:
2018
代理人:
摘要:
The present invention relates to a pharmaceutical product for the treatment of a proliferative disease, comprising the combination of an antibody, or an antigen-binding portion thereof, that specifically binds to human CD40 and a PD-L1 antibody and optionally a 3rd component which comprises as an active ingredient a cytokine inhibitor.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充